Véronique Brouste

5.1k total citations
98 papers, 3.3k citations indexed

About

Véronique Brouste is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Véronique Brouste has authored 98 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 26 papers in Cancer Research. Recurrent topics in Véronique Brouste's work include Breast Cancer Treatment Studies (22 papers), Breast Lesions and Carcinomas (17 papers) and Sarcoma Diagnosis and Treatment (17 papers). Véronique Brouste is often cited by papers focused on Breast Cancer Treatment Studies (22 papers), Breast Lesions and Carcinomas (17 papers) and Sarcoma Diagnosis and Treatment (17 papers). Véronique Brouste collaborates with scholars based in France, United States and Switzerland. Véronique Brouste's co-authors include Gaëtan MacGrogan, Simone Mathoulin‐Pélissier, Marc Debled, C. Tunon de Lara, Carine Bellera, Eberhard Stoeckle, Pierre Soubeyran, Jean‐Yves Blay, Sébastien Salas and Sylvie Bonvalot and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Véronique Brouste

96 papers receiving 3.2k citations

Peers

Véronique Brouste
Heather Lin United States
Saveli Goldberg United States
David Joseph Australia
Nabil Wasif United States
Véronique Brouste
Citations per year, relative to Véronique Brouste Véronique Brouste (= 1×) peers Annalisa Trama

Countries citing papers authored by Véronique Brouste

Since Specialization
Citations

This map shows the geographic impact of Véronique Brouste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Brouste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Brouste more than expected).

Fields of papers citing papers by Véronique Brouste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Brouste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Brouste. The network helps show where Véronique Brouste may publish in the future.

Co-authorship network of co-authors of Véronique Brouste

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Brouste. A scholar is included among the top collaborators of Véronique Brouste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Brouste. Véronique Brouste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Darbo, Élodie, Marc Debled, Véronique Brouste, et al.. (2022). An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy. ESMO Open. 7(4). 100502–100502. 8 indexed citations
2.
Jones, Natalie, Audrey Gros, Valérie Velasco, et al.. (2022). PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas. Cancer Genetics. 264-265. 8–15. 3 indexed citations
3.
Bonhomme, Benjamin, Brigitte Le Bail, Serge Évrard, et al.. (2019). Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False. Clinical Medicine Insights Oncology. 13. 2280521194–2280521194. 13 indexed citations
4.
Debled, Marc, Valérie Velasco, C. Tunon de Lara, et al.. (2019). Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 179(1). 11–23. 32 indexed citations
5.
Crombé, Amandine, Xavier Buy, Eberhard Stoeckle, et al.. (2019). Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient Outcome. Radiology. 291(3). 710–721. 119 indexed citations
6.
Leroy, Laura, Julien Adam, Véronique Brouste, et al.. (2017). IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis. Annals of Oncology. 28. v417–v417. 2 indexed citations
7.
Latorzeff, I., Aude Fléchon, Guilhem Roubaud, et al.. (2017). Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study. PLoS ONE. 12(4). e0174978–e0174978. 16 indexed citations
8.
Désolneux, G., Véronique Brouste, Marianne Fonck, et al.. (2015). Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only. PLoS ONE. 10(3). e0122816–e0122816. 34 indexed citations
9.
Debled, Marc, Marion Fournier, Aline Papaxanthos-Roche, et al.. (2015). Oncofertilité du cancer du sein : d’où vient-on, où allons-nous ?. Bulletin du Cancer. 102(6). 489–496.
10.
Désolneux, G., et al.. (2014). Patterns of complications following intraoperative radiofrequency ablation for liver metastases. HPB. 16(11). 1002–1008. 6 indexed citations
11.
MacGrogan, Gaëtan, et al.. (2013). Imaging features of sporadic breast cancer in women under 40 years old: 97 cases. European Radiology. 23(12). 3237–3245. 34 indexed citations
12.
Évrard, Serge, Véronique Brouste, Pippa McKelvie‐Sebileau, & G. Désolneux. (2013). Liver metastases in close contact to hepatic veins ablated under vascular exclusion. European Journal of Surgical Oncology. 39(12). 1400–1406. 6 indexed citations
13.
Soubeyran, Pierre, Marianne Fonck, C. Blanc-Bisson, et al.. (2012). Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer. Journal of Clinical Oncology. 30(15). 1829–1834. 305 indexed citations
14.
Boisserie-Lacroix, M., et al.. (2012). Radiological features of triple-negative breast cancers (73 cases). Diagnostic and Interventional Imaging. 93(3). 183–190. 52 indexed citations
15.
Toulmonde, Maud, Nicolas Madranges, Véronique Brouste, et al.. (2012). Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity. Breast Cancer Research and Treatment. 134(1). 325–332. 13 indexed citations
16.
Palussière, Jean, L. Mauriac, Véronique Brouste, et al.. (2012). Radiofrequency Ablation as a Substitute for Surgery in Elderly Patients with Nonresected Breast Cancer: Pilot Study with Long-term Outcomes. Radiology. 264(2). 597–605. 45 indexed citations
17.
Salas, Sébastien, Armelle Dufresne, Binh Bui, et al.. (2011). Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation. Journal of Clinical Oncology. 29(26). 3553–3558. 268 indexed citations
18.
Soubeyran, Isabelle, Thierry Lesté-Lasserre, Guillaume Drutel, et al.. (2011). Tissue Microarray Cytometry Reveals Positive Impact of Homeodomain Interacting Protein Kinase 2 in Colon Cancer Survival Irrespective of p53 Function. American Journal Of Pathology. 178(5). 1986–1998. 13 indexed citations
19.
Debled, Marc, Gaëtan MacGrogan, Véronique Brouste, et al.. (2010). Is it useful to detect lymphovascular invasion in lymph node‐positive patients with primary operable breast cancer?. Cancer. 116(13). 3093–3101. 29 indexed citations
20.
Salas, Sébastien, B. Bui, Eberhard Stoeckle, et al.. (2009). Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database. Annals of Oncology. 20(6). 1127–1135. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026